New approach for monitoring minimum residual disease in multiple myelomaMarch 17, 2017Multiple MyelomaHematologic Malignancies
Consensus Statement Supporting the Recommendation for Single-Fraction Palliative Radiotherapy for Uncomplicated, Painful Bone MetastasesMarch 6, 2017Multiple MyelomaHematologic Malignancies
‘Strong evidence’ links obesity to cancersFebruary 28, 2017ObesityOncologyMultiple MyelomaBreast CancerHematologic Malignancies
Phase III trial: VZV protects auto-HCT patientsFebruary 25, 2017Multiple MyelomaInfectious DiseasesVaccinesOncologyHematologic Malignancies
Guidelines tackle long-term screening, management of myelomaFebruary 25, 2017Multiple MyelomaOncologyRare Diseases
Multiple Myeloma and Stroke: What’s the Risk?January 10, 2017Multiple MyelomaHematologic MalignanciesMultiple Myeloma
Study Points to Risk Factors for LymphomaOctober 5, 2016OncologyHematologic MalignanciesMultiple Myeloma
Can Serum Free Light Chains Be Used for the Early Diagnosis of Monoclonal Immunoglobulin-Secreting B-Cell and Plasma-Cell Diseases? (FULL)August 26, 2016OncologyHematologic MalignanciesMultiple Myeloma
Daratumumab Effective in Combo RegimenAugust 10, 2016Multiple MyelomaOncologyHematologic MalignanciesMultiple Myeloma
SU2C announces researcher-industry collaboration on immunotherapyJuly 13, 2016Genitourinary CancerMelanomaMultiple MyelomaImmuno-oncology
